Glenmark Pharmaceuticals
GLENMARK.NS
#2738
Rank
A$7.36 B
Marketcap
$26.09
Share price
0.59%
Change (1 day)
36.44%
Change (1 year)

Earnings for Glenmark Pharmaceuticals (GLENMARK.NS)

Earnings in 2024 (TTM): A$0.40 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company's current earnings are A$1.53 Billion. , an increase over its 2023 earnings that were of -A$95.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Glenmark Pharmaceuticals from 2012 to 2024

Annual earnings

Year Earnings Change
2024 A$0.41 B-529.64%
2023 -A$95.91 Million-129.25%
2022 A$0.32 B-13.93%
2021 A$0.38 B4.71%
2020 A$0.36 B18.76%
2019 A$0.30 B-15.93%
2018 A$0.36 B36.53%
2017 A$0.26 B-31.84%
2016 A$0.39 B66.82%
2015 A$0.23 B8.58%
2014 A$0.21 B-18.39%
2013 A$0.26 B3.66%
2012 A$0.25 B